P53 has been proved to have tumor suppressor function, which can inhibit the expression of pyruvate dehydrogenase kinase 2 (PDK2), thus activating mitochondrial oxidative metabolism and promoting TCA cycle (Zhang et al. 2013; Harlander et al. 2017). Here, TP53 is linked to neoplasm.